The drug does not fix the underlying pattern
A quality GLP-1 weight loss program review always emphasises informed consent and education
We used the following keywords: GLP-1, GLP-1 receptor agonist, exenatide, liraglutide, lixisenatide, semaglutide, albiglutide, dulaglutide, efpeglenatide, coronary artery disease, coronary atherosclerosis, endothelial dysfunction, inflammation, body weight, blood pressure, lipids, aggregation, coagulation, coronary vasospasm, coronary vasodilation, coronary microvascular, acute coronary syndrome, myocardial infarction, unstable angina, stable angina, chronic coronary syndrome, vasospastic angina, microvascular angina, coronary revascularization
Providers review a patient's BMI, medical history, weight-related conditions, and previous lifestyle attempts to determine if medication is appropriate